ABBV vs PFE: Stock Comparison
Key metrics
| Metric | ABBV | PFE |
|---|---|---|
| Price | $285.46 | $29.80 |
| Market cap | $504.44B | $169.88B |
| P/E | 80.07 | 39.21 |
| Revenue growth | +8.57% | -1.65% |
| Operating margin | +29.32% | +26.72% |
| Dividend yield | 2.42% | 5.77% |
| 1-year total return | +29.35% | +30.10% |
| 3-year total return | +127.76% | +19.98% |
| 5-year total return | +215.55% | -10.11% |
Performance
Total return (%)
Date
ABBVPFE
Total return from Oct 8, 2021 to Oct 27, 2026, rebased to the first date.
Which is better for...
- Income. PFE yields more, at 5.77% versus 2.42% for ABBV.
- The past year. PFE returned more, at +30.10% versus +29.35% for ABBV.
- Valuation. PFE has the lower trailing P/E, at 39.21 versus 80.07 for ABBV.
- Growth. ABBV has faster revenue growth, at +8.57% versus -1.65% for PFE.
- The past five years. ABBV returned more, at +215.55% versus -10.11% for PFE.
These lines restate the figures above. They are not a recommendation.
Frequently asked questions
What is the market cap of ABBV vs PFE?
AbbVie Inc. (ABBV) has a market cap of $504.44B. Pfizer Inc. (PFE) has a market cap of $169.88B.
How did ABBV and PFE perform over the past year?
The 1-year total return is +29.35% for ABBV and +30.10% for PFE.
Which has the higher dividend yield, ABBV or PFE?
ABBV's dividend yield is 2.42%. PFE's dividend yield is 5.77%.
What is the 5-year total return of ABBV vs PFE?
The 5-year total return is +215.55% for ABBV and -10.11% for PFE.
Is this comparison investment advice?
No. This page reports published figures for ABBV and PFE. It is not a recommendation.